High Tide Reports Third Consecutive Quarter of Record Revenue and Adjusted EBITDA of $118.1 Million and $6.6 Million, Respectively
Ryan Allway June 14th, 2023 News, Top News, Top Story The Company Achieved Significant Sequential Improvement in Cost Reduction in Line With Its Goal to Achieve Positive Free Cash Flow by the End of This Calendar Year This news release constitutes a “designated news release” for the purposes of... Read more
Decibel Announces First Quarter Results with Record $27.1 Million of Net Revenue, $6.8 Million of Adjusted EBITDA, and $0.01 of Adjusted EPS
Ryan Allway May 29th, 2023 News, Top News CALGARY, AB, May 29, 2023 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce its interim financial results for the three month period ending March... Read more
Ryan Allway December 13th, 2022 News, Top News Revenue of $5.07M compared to $3.76M in Q4 2021, an increase of 35% Adjusted EBITDA1 (aEBITDA) of $1.66M compared to $1.2M in Q4 2021, an increase of 39% Positive free cash flow for Q4 2022 and fiscal 2022 Subsequent to quarter-end, closed a $2.0M convertible debenture financing MEDFORD, Ore., Dec. 13, 2022 /CNW/ – Grown... Read more
CordovaCann (CSE:CDVA / OTCQB:LVRLF) Provides Update on Star Buds Cannabis Co. Retail Operation
Ryan Allway September 6th, 2022 News, Top News Star Buds Cannabis Co. Achieved Record Monthly Revenues in August TORONTO, ON / ACCESSWIRE / September 6, 2022 / CordovaCann Corp. (CSE:CDVA) (OTCQB:LVRLF) (“Cordova” or the “Company”), a cannabis-focused consumer products company, is pleased to provide an update on its Star Buds... Read more
Bloomios Reports 2021 Revenue at Record $8.5 Million, up from $1.3 Million in 2020
Ryan Allway April 19th, 2022 News, Top News SANTA BARBARA, Calif., April 19, 2022 /PRNewswire/ — Bloomios, Inc. (OTCQB: BLMS), a leading hemp and nutraceutical manufacturer specializing in full service product development, R&D and compliance solutions, reported results for the fourth quarter and full year ended December 31, 2021. All comparisons are to the... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )